secwatch.observer — SEC 8-K summary
======================================

Issuer:     Scienture Holdings, Inc. (SCNX)
CIK:        0001382574
Form:       8-K
Filed at:   2023-06-23T23:59:59+00:00
Accession:  0001493152-23-022184
Event type: m_and_a
Sentiment:  positive
Materiality: 0.75
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TRxADE Health signs binding LOI to acquire Superlatus, pivoting to food technology
--------------------------------------------------------------------------------

- Superlatus shareholders receive 30,821,918 MEDS shares valued at $7.30 per share, comprising 19.99% of post-merger common stock and remainder in non-voting preferred.
- Merger conditions include Superlatus acquiring Sapientia and Prestige Farms; combined valuation target of at least $225M.
- TRxADE plans to divest its existing pharmaceutical exchange business after closing.
- Expected close in late Q3 or early Q4 2023, subject to due diligence, audited financials, Nasdaq approval.
- Board of both companies unanimously approved LOI.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/0001493152-23-022184-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1382574/000149315223022184/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-022184

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer